 DIAPRESAN D
|
Montpellier
|
| valsartán+hidroclorotiazida |
Antihipertensivo |
| 160/12.5 mg comp.rec.x30 | $31.827,98 | (13/03/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $13.048,79 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.399,94 AF $12.428,04 |
|
|
|
|
| 160/25 mg comp.rec.x30 | $36.709,07 | (23/04/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $15.120,53 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $24.255,32 AF $12.453,75 |
|
|
|
|
| 320/12.5 mg comp.rec.x30 | $40.131,52 | (23/04/25) |
| PAMI |
|
| AF $14.286,96 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $25.063,23 AF $15.068,29 |
|
|
|
|
| 320/25 mg comp.rec.x30 | $40.376,55 | (23/04/25) |
|
|
|
| 80/12.5 mg comp.rec.x 30 | $25.692,00 | (02/11/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $10.138,18 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $17.759,00 AF $7.933,00 |
|
|
|
|
| |
